Persistence of middle-ear effusion after acute otitis media in children.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 431635)

Published in N Engl J Med on May 17, 1979

Authors

P A Shurin, S I Pelton, A Donner, J O Klein

Articles by these authors

The impact of patient-centered care on outcomes. J Fam Pract (2000) 15.07

Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol (1981) 9.21

WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet (2001) 6.86

Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80

Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57

Small sample performance of tests of homogeneity of odds ratios in K 2 x 2 tables. Stat Med (1992) 6.20

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis (1989) 5.87

Evaluation of a palliative care service: problems and pitfalls. BMJ (1994) 5.70

Developments in cluster randomized trials and Statistics in Medicine. Stat Med (2007) 4.12

Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med (1993) 3.67

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA (2000) 3.42

Approaches to sample size estimation in the design of clinical trials--a review. Stat Med (1984) 3.28

Sample size requirements for reliability studies. Stat Med (1987) 3.15

Analysis of data arising from a stratified design with the cluster as unit of randomization. Stat Med (1987) 3.01

Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79

The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis (1981) 2.76

Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics (1986) 2.62

Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ (1999) 2.48

Microbiology of otitis media. Ann Otol Rhinol Laryngol Suppl (1981) 2.46

Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31

The genital mycoplasmas. N Engl J Med (1973) 2.21

Parents, physicians, and antibiotic use. Pediatrics (1999) 2.18

The merits of matching in community intervention trials: a cautionary tale. Stat Med (1997) 2.14

Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. Greater Boston Otitis Media Study Group. J Infect Dis (1990) 2.14

Susceptibility of genital mycoplasmas to antimicrobial agents. Appl Microbiol (1970) 2.13

Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest (1985) 2.09

The estimation of intraclass correlation in the analysis of family data. Biometrics (1980) 2.06

Isolation of viruses and mycoplasmas from middle ear effusions: a review. Ann Otol Rhinol Laryngol (1976) 2.04

Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04

THE NEW PENICILINS. N Engl J Med (1963) 2.02

Methodologic investigations and prevalence of genital mycoplasmas in pregnancy. J Infect Dis (1970) 2.02

Adjustments to the Mantel-Haenszel chi-square statistic and odds ratio variance estimator when the data are clustered. Stat Med (1987) 2.00

Colonization of newborn infants by mycoplasmas. N Engl J Med (1969) 1.98

Responsiveness of the short form-36, disability of the arm, shoulder, and hand questionnaire, patient-rated wrist evaluation, and physical impairment measurements in evaluating recovery after a distal radius fracture. J Hand Surg Am (2000) 1.98

Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med (1973) 1.92

Acute otitis media in children. Serologic studies and attempts to isolate viruses and mycoplasmas from aspirated middle-ear fluids. N Engl J Med (1967) 1.87

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86

Do family physicians need medical assistants to detect and manage hypertension? CMAJ (1986) 1.85

Current and future challenges in the design and analysis of cluster randomization trials. Stat Med (2001) 1.80

Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79

Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis (1987) 1.77

Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol Suppl (1981) 1.77

Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother (1977) 1.75

A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr (1986) 1.72

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus. Am J Dis Child (1971) 1.71

Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr (1980) 1.69

Construction of confidence limits about effect measures: a general approach. Stat Med (2008) 1.69

Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens. J Infect Dis (1985) 1.67

Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis (1983) 1.62

Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59

Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic. J Pediatr (1975) 1.55

Clinical spectrum of gonococcal infection in women. Lancet (1977) 1.49

Pneumococcal vaccine for Olympic athletes and visitors to Spain. N Engl J Med (1992) 1.48

Birth weight and genital mycoplasmas in pregnancy. N Engl J Med (1971) 1.48

Letter: The issue of prophylaxis of neonatal group B streptococcal infections. J Pediatr (1973) 1.48

Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8. BMJ (2011) 1.48

The promise of immunoprophylaxis for prevention of acute otitis media. Pediatr Infect Dis J (1999) 1.47

Patient versus injury factors as predictors of pain and disability six months after a distal radius fracture. J Clin Epidemiol (2002) 1.46

Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species. Antimicrob Agents Chemother (1976) 1.43

Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J (1995) 1.42

Effect of intranasal reovirus infection on antibacterial activity of mouse lung. J Infect Dis (1969) 1.41

Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41

Randomised study of n of 1 trials versus standard practice. BMJ (1996) 1.41

Are ordinal models useful for classification? Stat Med (1991) 1.40

Meningitis and bacteremia due to Haemophilus influenzae: occurrence and mortality at Boston City Hospital in 12 selected years, 1935-1972. J Infect Dis (1974) 1.39

HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. J Virol (2000) 1.38

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine (2010) 1.37

Sepsis due to Escherichia coli in neonates with galactosemia. N Engl J Med (1977) 1.37

Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun (2000) 1.36

Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain? J Pediatr (1984) 1.36

Diagnosis and management of meningitis. Pediatr Infect Dis J (1992) 1.32

Proteus mirabilis infections in a hospital nursery traced to a human carrier. N Engl J Med (1971) 1.30

A regression approach to the analysis of data arising from cluster randomization. Int J Epidemiol (1985) 1.28

Otitis media with effusion during the first three years of life and development of speech and language. Pediatrics (1984) 1.28

Middle ear disease and the practice of pediatrics. Burden during the first five years of life. JAMA (1983) 1.27

An empirical study of cluster randomization. Int J Epidemiol (1982) 1.26

Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med (2001) 1.26

Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States. Drugs (1986) 1.26

Outcome of unsuspected pneumococcemia in children not initially admitted to the hospital. J Pediatr (1977) 1.25

Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". J Pediatr (1992) 1.25

Factors affecting the comparability of meta-analyses and largest trials results in perinatology. J Clin Epidemiol (1997) 1.24

Meningitis after lumbar puncture in children with bacteremia. N Engl J Med (1981) 1.24

Application of the McNemar test to non-independent matched pair data. Stat Med (1991) 1.22

Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine (2011) 1.22

'Appropriateness' of tympanostomy tubes. Setting the record straight. Arch Otolaryngol Head Neck Surg (1994) 1.21

Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin (1995) 1.21

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) (1988) 1.19

Levels of penicillin in serum of newborn infants. Am J Dis Child (1966) 1.18

Patterns of use of antibiotics in two newborn nurseries. N Engl J Med (1977) 1.18

Microbiology and antimicrobial treatment of otitis media. Ann Otol Rhinol Laryngol Suppl (1981) 1.18

Acute otitis media in children. Bacteriological findings in middle ear fluid obtained by needle aspiration. Am J Dis Child (1966) 1.17

Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry (1993) 1.16

Trimethoprim-sulfamethoxazole: absorption, excretion, and toxicity in six children. J Infect Dis (1973) 1.15

The design of controlled experiments in the evaluation of non-therapeutic interventions. J Chronic Dis (1982) 1.15

Workshop on effects of otitis media on the child. Pediatrics (1983) 1.15